Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 10-Minute daily app boost teen mental health?

NCT ID NCT07700264

Symptom relief Sponsor: Seoul Women's University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a mobile app called NEMO-I can help adolescents monitor and improve their emotional and cognitive health. The app offers seven brief, gamified activities—like facial expression imitation, singing, and mindfulness—that take about 10 minutes each day. Researchers will compare before-and-after assessments in 140 middle and high school students to see if the app reduces symptoms of depression and anxiety and improves attention and thinking skills.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NEMO-I (Neuro-cognitive Emotion Monitoring-Intervention), a gamified mobile application with brief psychological activities
What this could lead to
If effective, NEMO-I could provide a convenient, low-cost digital tool to help adolescents manage stress, anxiety, and mood in everyday life.
What could go wrong
This is a small, early-stage validation study with 140 participants, so results may not apply broadly. The app relies on self-reported use and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Middle or high school students currently enrolled in school * Using an Android-based smartphone * Voluntary agreement to participate, with consent from a legal guardian Exclusion Criteria: * Borderline intellectual functioning or intellectual disability (IQ below 80) * Visual or hearing impairment * Prior diagnosis of intellectual, visual, or hearing impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent - emotional problem are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent - emotional problem Adolescent mental health Cognition improvement

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Seoul Women's University

    Seoul, Seoul, 01797, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.